Skip Navigation

Cardiovascular Research 2007 75(2):240-246; doi:10.1016/j.cardiores.2007.03.024
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lowenstein, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lowenstein, C. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2007, European Society of Cardiology

Nitric oxide regulation of protein trafficking in the cardiovascular system

Charles J. Lowenstein*

The Johns Hopkins University School of Medicine, Baltimore, MD 21205, United States

* 950 Ross Bldg., 720 Rutland Ave. Tel.: +1 410 955 1530; fax: +1 410 955 0485. clowenst{at}jhmi.edu

Nitric oxide (NO) is a second messenger with diverse roles in the cardiovascular system, such as inhibiting thrombosis and limiting vascular inflammation. One mechanism by which NO modulates such disparate physiological processes is by regulating protein trafficking within cells. NO inhibits exocytosis of endothelial granules which would otherwise trigger inflammation. NO also blocks platelet secretion of granules that would otherwise activate thrombosis. NO decreases granule trafficking from the Golgi to the plasma membrane by targeting a key component of the exocytic machinery, N-ethylmaleimide sensitive factor (NSF). In contrast to its inhibitory effects on exocytosis, NO accelerates endocytosis. S-nitrosylation of dynamin increases its ability to hydrolyze GTP, assemble in oligomers around a nascent vesicle, and cleave the endocytic vesicle free from the plasma membrane. NO regulation of vesicle trafficking is a molecular mechanism that explains some of the cardiovascular effects of NO, and may be of broad physiological significance.

KEYWORDS Exocytosis; Inflammation; Endothelial; Platelet; Thrombosis; Vesicle; Trafficking; N-ethylmaleimide sensitive factor; SNARE


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
I. Malyukova, K. F. Murray, C. Zhu, E. Boedeker, A. Kane, K. Patterson, J. R. Peterson, M. Donowitz, and O. Kovbasnjuk
Macropinocytosis in Shiga toxin 1 uptake by human intestinal epithelial cells and transcellular transcytosis
Am J Physiol Gastrointest Liver Physiol, January 1, 2009; 296(1): G78 - G92.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
L. Genis, P. Gonzalo, A. S. Tutor, B. G. Galvez, A. Martinez-Ruiz, C. Zaragoza, S. Lamas, K. Tryggvason, S. S. Apte, and A. G. Arroyo
Functional interplay between endothelial nitric oxide synthase and membrane type 1 matrix metalloproteinase in migrating endothelial cells
Blood, October 15, 2007; 110(8): 2916 - 2923.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
S. Lamas, C. J. Lowenstein, and T. Michel
Nitric oxide signaling comes of age: 20 years and thriving
Cardiovasc Res, July 15, 2007; 75(2): 207 - 209.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.